Title: Indacaterol add-on therapy improves lung function, exercise capacity and life quality of COPD patients.
Journal: Advances in experimental medicine and biology 20130101
Title: Emerging Therapeutic Options for the Management of COPD.
Journal: Clinical medicine insights. Circulatory, respiratory and pulmonary medicine 20130101
Title: Indacaterol therapy in patients with COPD not receiving other maintenance treatment.
Journal: Respiratory medicine 20121201
Title: Assessing efficacy of indacaterol in moderate and severe COPD patients: a 12-week study in an Asian population.
Journal: Respiratory medicine 20121201
Title: An investigation into the structure-activity relationships associated with the systematic modification of the β(2)-adrenoceptor agonist indacaterol.
Journal: Bioorganic & medicinal chemistry letters 20121001
Title: Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.
Journal: The Cochrane database of systematic reviews 20120912
Title: Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison.
Journal: Thorax 20120901
Title: Limitations of model based dose selection for indacaterol in patients with chronic obstructive pulmonary disease.
Journal: International journal of clinical pharmacology and therapeutics 20120901
Title: Metabolism and pharmacokinetics of indacaterol in humans.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20120901
Title: Comment on the report 'limitations of model-based dose selection for indacaterol in patients with chronic obstructive pulmonary disease'.
Journal: International journal of clinical pharmacology and therapeutics 20120901
Title: Pharmacological characterization of abediterol, a novel inhaled β(2)-adrenoceptor agonist with long duration of action and a favorable safety profile in preclinical models.
Journal: The Journal of pharmacology and experimental therapeutics 20120801
Title: A year in review: new drugs for older adults in 2011.
Journal: The American journal of geriatric pharmacotherapy 20120801
Title: Systemic pharmacokinetics of indacaterol, an inhaled once-daily long-acting beta2-agonist, in different ethnic populations.
Journal: International journal of clinical pharmacology and therapeutics 20120801
Title: Pharmacology and therapeutics of bronchodilators.
Journal: Pharmacological reviews 20120701
Title: Indacaterol: a new long-acting β2-agonist in the management of chronic obstructive pulmonary disease.
Journal: Expert opinion on pharmacotherapy 20120501
Title: Validation of an on-line solid-phase extraction method coupled to liquid chromatography-tandem mass spectrometry detection for the determination of Indacaterol in human serum.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120501
Title: Indacaterol: a novel long-acting β(2) -agonist.
Journal: Pharmacotherapy 20120501
Title: ▾Indacaterol for COPD.
Journal: Drug and therapeutics bulletin 20120501
Title: Efficacy of once-daily indacaterol relative to alternative bronchodilators in COPD: a patient-level mixed treatment comparison.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120501
Title: Indacterol (Arcapta Neohaler) for COPD.
Journal: The Medical letter on drugs and therapeutics 20120430
Title: Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis.
Journal: Journal of clinical pharmacy and therapeutics 20120401
Title: Slow receptor dissociation is not a key factor in the duration of action of inhaled long-acting β2-adrenoceptor agonists.
Journal: British journal of pharmacology 20120401
Title: Indacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease.
Journal: Drugs 20120305
Title: Annual drug update: 2011 in review.
Journal: The Nurse practitioner 20120212
Title: Efficacy and safety of indacaterol 150 and 300 µg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: a 12-week, placebo-controlled study.
Journal: Respirology (Carlton, Vic.) 20120201
Title: Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease.
Journal: Drugs 20120122
Title: About the role of indacaterol in obstructive airways disorder: CON.
Journal: Revista portuguesa de pneumologia 20120101
Title: Acute effects of indacaterol on lung hyperinflation in moderate COPD: a comparison with tiotropium.
Journal: Respiratory medicine 20120101
Title: From libraries to candidate: the discovery of new ultra long-acting dibasic β₂-adrenoceptor agonists.
Journal: Bioorganic & medicinal chemistry letters 20120101
Title: About the role of indacaterol in obstructive airways disorder: PRO.
Journal: Revista portuguesa de pneumologia 20120101
Title: Achieving symptom control in patients with moderate asthma.
Journal: Clinical medicine insights. Circulatory, respiratory and pulmonary medicine 20120101
Title: Left-shifted nav channels in injured bilayer: primary targets for neuroprotective nav antagonists?
Journal: Frontiers in pharmacology 20120101
Title: Comparative efficacy of indacaterol in chronic obstructive pulmonary disease.
Journal: International journal of chronic obstructive pulmonary disease 20120101
Title: Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patients.
Journal: International journal of chronic obstructive pulmonary disease 20120101
Title: Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts.
Journal: Respiratory research 20120101
Title: Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease.
Journal: The Cochrane database of systematic reviews 20120101
Title: A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD.
Journal: BMJ open 20120101
Title: Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium.
Journal: Respiratory research 20120101
Title: Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis.
Journal: International journal of chronic obstructive pulmonary disease 20120101
Title: The risks and benefits of indacaterol--the FDA's review.
Journal: The New England journal of medicine 20111215
Title: Efficacy of indacaterol in the treatment of patients with COPD.
Journal: Primary care respiratory journal : journal of the General Practice Airways Group 20111201
Title: Muscarinic receptor subtypes and signalling involved in the attenuation of isoprenaline-induced rat urinary bladder relaxation.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20111201
Title: Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
Journal: Clinical therapeutics 20111201
Title: [Indacaterol (Onbrez Breezhaler), oral inhalation].
Journal: Journal de pharmacie de Belgique 20111201
Title: Application of latent growth and growth mixture modeling to identify and characterize differential responders to treatment for COPD.
Journal: Contemporary clinical trials 20111101
Title: Cost-utility analysis of indacaterol in Germany: a once-daily maintenance bronchodilator for patients with COPD.
Journal: Respiratory medicine 20111101
Title: Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
Journal: The European respiratory journal 20111001
Title: Profiling the bronchodilator effects of the novel ultra-long-acting β2-agonist indacaterol against established treatments in chronic obstructive pulmonary disease.
Journal: Therapeutic advances in respiratory disease 20111001
Title: Effect of indacaterol on dynamic lung hyperinflation and breathlessness in hyperinflated patients with COPD.
Journal: COPD 20111001
Title: Indacaterol.
Journal: COPD 20111001
Title: Association of house dust mite-specific IgE with asthma control, medications and household pets.
Journal: Asia Pacific allergy 20111001
Title: Indacaterol. A long-acting beta-2 agonist, no advantages in COPD.
Journal: Prescrire international 20110901
Title: [Medication of the month. Indacaterol (Onbrez Breezhaler) and chronic obstructive pulmonary disease].
Journal: Revue medicale de Liege 20110901
Title: Long-term safety and efficacy of indacaterol, a long-acting β₂-agonist, in subjects with COPD: a randomized, placebo-controlled study.
Journal: Chest 20110701
Title: Effect of indacaterol on exercise endurance and lung hyperinflation in COPD.
Journal: Respiratory medicine 20110701
Title: Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD.
Journal: Respiratory medicine 20110601
Title: β(2) -adrenoceptor agonists: current and future direction.
Journal: British journal of pharmacology 20110501
Title: Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week study.
Journal: Respiratory medicine 20110501
Title: The reassertion profiles of long acting β2-adrenoceptor agonists in the guinea pig isolated trachea and human recombinant β2-adrenoceptor.
Journal: Pulmonary pharmacology & therapeutics 20110401
Title: Cardio- and cerebrovascular safety of indacaterol vs formoterol, salmeterol, tiotropium and placebo in COPD.
Journal: Respiratory medicine 20110401
Title: Sustained 24-hour efficacy of once daily indacaterol (300 μg) in patients with chronic obstructive pulmonary disease: a randomized, crossover study.
Journal: Pulmonary pharmacology & therapeutics 20110201
Title: Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison.
Journal: The European respiratory journal 20110201
Title: An update on the use of indacaterol in patients with COPD.
Journal: Therapeutic advances in respiratory disease 20110201
Title: Safety, tolerability and pharmacokinetics of single escalating doses of indacaterol, a once-daily beta2-agonist bronchodilator, in subjects with COPD.
Journal: International journal of clinical pharmacology and therapeutics 20110201
Title: Indacaterol: pharmacologic profile, efficacy and safety in the treatment of adults with COPD.
Journal: Expert review of respiratory medicine 20110201
Title: [Pulmonary medicine. Two new drugs for the treatment of COPD].
Journal: Revue medicale suisse 20110119
Title: Application of the classical Einthoven model of bronchoconstriction to the study of inhaled bronchodilators in rodents.
Journal: Journal of pharmacological and toxicological methods 20110101
Title: Efficacy, safety and pharmacokinetics of indacaterol in Caucasian and Japanese patients with chronic obstructive pulmonary disease: a comparison of data from two randomized, placebo-controlled studies.
Journal: Clinical drug investigation 20110101
Title: Optimizing management of chronic obstructive pulmonary disease in the upcoming decade.
Journal: International journal of chronic obstructive pulmonary disease 20110101
Title: [New drugs in chronic obstructive pulmonary disease].
Journal: Pneumonologia i alergologia polska 20110101
Title: Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approaches.
Journal: Respiratory research 20110101
Title: [Novel controllers of airway obstruction in COPD patients].
Journal: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20110101
Title: [Indacaterol--a new hope for maximising bronchodilation?].
Journal: Pneumologia (Bucharest, Romania) 20110101
Title: Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study.
Journal: BMC pulmonary medicine 20110101
Title: Comparative efficacy of indacaterol 150 μg and 300 μg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease--a network meta-analysis.
Journal: International journal of chronic obstructive pulmonary disease 20110101
Title: Real time analysis of β(2)-adrenoceptor-mediated signaling kinetics in human primary airway smooth muscle cells reveals both ligand and dose dependent differences.
Journal: Respiratory research 20110101
Title: Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPD.
Journal: International journal of chronic obstructive pulmonary disease 20110101
Title: Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol.
Journal: International journal of chronic obstructive pulmonary disease 20110101
Title: Dose-response curve to salbutamol during acute and chronic treatment with formoterol in COPD.
Journal: International journal of chronic obstructive pulmonary disease 20110101
Title: Emerging therapies for severe asthma.
Journal: BMC medicine 20110101
Title: Roflumilast, indacaterol maleate, and abiraterone acetate.
Journal: Journal of the American Pharmacists Association : JAPhA 20110101
Title: Bronchodilator efficacy and safety of indacaterol 150 μg once daily in patients with COPD: an analysis of pooled data.
Journal: International journal of chronic obstructive pulmonary disease 20110101
Title: Safety of indacaterol in the treatment of patients with COPD.
Journal: International journal of chronic obstructive pulmonary disease 20110101
Title: Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients.
Journal: International journal of chronic obstructive pulmonary disease 20110101
Title: Implementing chronic care for COPD: planned visits, care coordination, and patient empowerment for improved outcomes.
Journal: International journal of chronic obstructive pulmonary disease 20110101
Title: Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis.
Journal: Respiratory research 20110101
Title: Indacaterol: in chronic obstructive pulmonary disease.
Journal: Drugs 20101203
Title: Indacaterol once-daily is equally effective dosed in the evening or morning in COPD.
Journal: Respiratory medicine 20101201
Title: QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease.
Journal: Thorax 20101201
Title: Cardiovascular safety of QVA149, a combination of Indacaterol and NVA237, in COPD patients.
Journal: COPD 20101201
Title: [Indacaterol is a new once-daily beta2-agonist for treatment of COPD].
Journal: Ugeskrift for laeger 20101122
Title: 24-h bronchodilator efficacy of single doses of indacaterol in Japanese patients with asthma: a comparison with placebo and salmeterol.
Journal: Respiratory medicine 20101101
Title: Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol.
Journal: Current medical research and opinion 20101101
Title: Bronchodilator efficacy of single doses of indacaterol in Japanese patients with COPD: A randomised, double-blind, placebo-controlled trial.
Journal: Allergology international : official journal of the Japanese Society of Allergology 20100901
Title: A physical properties based approach for the exploration of a 4-hydroxybenzothiazolone series of beta2-adrenoceptor agonists as inhaled long-acting bronchodilators.
Journal: Bioorganic & medicinal chemistry letters 20100901
Title: Efficacy is a contributing factor to the clinical onset of bronchodilation of inhaled beta(2)-adrenoceptor agonists.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20100901
Title: [Germany's Novartis Chief proposes 'More competition through decentralized contracts'].
Journal: MMW Fortschritte der Medizin 20100812
Title: Indacaterol maleate for the treatment of chronic obstructive pulmonary disease.
Journal: Expert opinion on pharmacotherapy 20100801
Title: Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium.
Journal: American journal of respiratory and critical care medicine 20100715
Title: Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design.
Journal: Pulmonary pharmacology & therapeutics 20100601
Title: New options for bronchodilator treatment in COPD.
Journal: Thorax 20100601
Title: Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD.
Journal: Thorax 20100601
Title: [Diseases of the lung and air passages 2010].
Journal: Deutsche medizinische Wochenschrift (1946) 20100601
Title: The identification of indacaterol as an ultralong-acting inhaled beta2-adrenoceptor agonist.
Journal: Journal of medicinal chemistry 20100513
Title: The short, the long and the 'ultra-long': why duration of bronchodilator action matters in chronic obstructive pulmonary disease.
Journal: Advances in therapy 20100301
Title: Indacaterol for chronic obstructive pulmonary disease (COPD).
Journal: Drugs of today (Barcelona, Spain : 1998) 20100301
Title: Novel bronchodilators in asthma.
Journal: Current opinion in pulmonary medicine 20100101
Title: Efficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week study.
Journal: BMC pulmonary medicine 20100101
Title: [Efficacy and safety of indacaterol - new long-acting beta(2) agonist].
Journal: Pneumonologia i alergologia polska 20100101
Title: Impact of bronchodilator therapy on exercise tolerance in COPD.
Journal: International journal of chronic obstructive pulmonary disease 20100101
Title: Onset of action of indacaterol in patients with COPD: comparison with salbutamol and salmeterol-fluticasone.
Journal: International journal of chronic obstructive pulmonary disease 20100101
Title: Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium.
Journal: Respiratory research 20100101
Title: Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents.
Journal: Respiratory research 20100101
Title: Lipid membrane interactions of indacaterol and salmeterol: do they influence their pharmacological properties?
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20091208
Title: Effect of pre-contraction on β-adrenoceptor-mediated relaxation of rat urinary bladder.
Journal: World journal of urology 20091201
Title: Bronchodilator effects of indacaterol and formoterol in patients with COPD.
Journal: Pulmonary pharmacology & therapeutics 20091201
Title: 24-hour bronchodilator efficacy of single doses of indacaterol in patients with persistent asthma: comparison with placebo and formoterol.
Journal: Current medical research and opinion 20091001
Title: The long-acting beta-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells.
Journal: British journal of pharmacology 20090901
Title: Pharmacogenetic characterization of indacaterol, a novel beta 2-adrenoceptor agonist.
Journal: British journal of pharmacology 20090901
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20090901
Title: Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases.
Journal: Advances in therapy 20090701
Title: Mometasone furoate: an effective anti-inflammatory with a well-defined safety and tolerability profile in the treatment of asthma.
Journal: International journal of clinical practice 20090501
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20090401
Title: 24-hour bronchodilator efficacy of single doses of indacaterol in subjects with COPD: comparison with placebo and formoterol.
Journal: Current medical research and opinion 20090201
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20090101
Title: Indacaterol, A Novel Once Daily Inhaled beta2-Adrenoreceptor Agonist.
Journal: The open respiratory medicine journal 20090101
Title: Indacaterol: a new once daily long-acting beta(2) adrenoceptor agonist.
Journal: Core evidence 20090101
Title: Efficacy and safety of indacaterol, a new 24-hour beta2-agonist, in patients with asthma: a dose-ranging study.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma 20081201
Title: Novel long-acting bronchodilators for COPD and asthma.
Journal: British journal of pharmacology 20081001
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20081001
Title: A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison.
Journal: Respiratory medicine 20080701
Title: Bronchodilator efficacy of indacaterol, a novel once-daily beta2-agonist, in patients with persistent asthma.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20080701
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20080501
Title: New approaches to managing asthma: a US perspective.
Journal: Therapeutics and clinical risk management 20080401
Title: Pharmacological characterization of indacaterol, a novel once daily inhaled 2 adrenoceptor agonist, on small airways in human and rat precision-cut lung slices.
Journal: The Journal of pharmacology and experimental therapeutics 20080101
Title: Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study.
Journal: Allergy 20080101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20080101
Title: A cell-based assay to assess the persistence of action of agonists acting at recombinant human beta(2) adrenoceptors.
Journal: Journal of pharmacological and toxicological methods 20080101
Title: Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthma.
Journal: Current medical research and opinion 20071201
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20071201
Title: Tolerability of indacaterol, a novel once-daily beta2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20071201
Title: Safety and tolerability of indacaterol in asthma: a randomized, placebo-controlled 28-day study.
Journal: Respiratory medicine 20071001
Title: Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma.
Journal: The European respiratory journal 20070501
Title: Effect of indacaterol, a novel long-acting beta2-agonist, on isolated human bronchi.
Journal: The European respiratory journal 20070301
Title: Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial.
Journal: Pulmonary pharmacology & therapeutics 20070101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20070101
Title: ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD?
Journal: Drugs 20070101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20061201
Title: In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.
Journal: The Journal of pharmacology and experimental therapeutics 20060501
Title: Indacaterol Novartis/skyePharma.
Journal: Current opinion in investigational drugs (London, England : 2000) 20060501
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20060501
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20060101
Title: Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease.
Journal: Expert opinion on investigational drugs 20050701
Title: Absorption and transport of exogenous protein in the archinephric duct of the opisthonephric kidney of the sea lamprey, Petromyzon marinus L.
Journal: Comparative biochemistry and physiology. A, Comparative physiology 19751201
